trending Market Intelligence /marketintelligence/en/news-insights/trending/oockcwmkanp19jdzoromiw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cellect Biotechnology appoints chief business officer

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Cellect Biotechnology appoints chief business officer

Israel-based Cellect Biotechnology Ltd. named Andrew Sabatier as its chief business officer to head its U.S. center of operations.

Sabatier was most recently leading GE Cell Therapy's sales and market development for U.S. and Canada. Prior to joining GE, he was the sales vice president of Biosafe America Inc., a company acquired by General Electric Co.

Cellect Biotechnology is a biotechnology focused on developing technologies for selecting stem cells from any given tissue to improve a variety of related therapies.